Clinical Trials Logo

Clinical Trial Summary

Decisional regret is a negative feeling, involving distress or remorse following a decision. This has been studied in several areas such as psychology, economy or marketing. Patients suffering from end-stage renal disease may choose between dialysis and transplantation. This decision-making process is shared with the nephrologist, who explained to the patient the pros and cons of these two possibilities. Although transplantation offers a better life expectancy and quality of life than dialysis, nothing is known about the proportion of patients regretting their choice to be transplanted. The DONOR study aims to determine the proportion of patients regretting their decision, in a prospective cohort of renal transplant recipients. The decisional regret will be assessed by the DRS ("Decisional Regret Scale"), associated with the RetransQoL, a quality of life questionnaire.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Renal Transplant Candidate for Left Kidney
  • Renal Transplant Candidate for Right Kidney

NCT number NCT05282381
Study type Observational
Source University Hospital, Lille
Contact Mehdi Maanaoui, MD
Phone 0320445962
Email mehdi.maanaoui@chru-lille.fr
Status Recruiting
Phase
Start date February 1, 2022
Completion date July 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05411744 - One-month Latent Tuberculosis Treatment for Renal Transplant Candidates Phase 4
Completed NCT01431430 - VITamine D Supplementation in RenAL Transplant Recipients - VITALE Phase 4
Completed NCT01344434 - ACToR-study : Angiographic CT of Renal Transplantation Candidate - Study N/A